×
Seguir

Artax Biopharma

Startup

Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammato

SECTORES

WEB OFICIAL

About Artax Biopharma

Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T-cell activation. Specific control over T-cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.

Image Gallery Artax Biopharma 1

Images from Artax Biopharma

Data Artax Biopharma

Offices
Locations
Total inversión 1.520.000€
Rondas inversión
  • Early/Startup
    NO DISPONIBLE

Equipo Artax Biopharma 1

Inversores Artax Biopharma 4

Acceleradoras Artax Biopharma 0

Artax Biopharma no ha pasado por aceleradoras

Noticias Artax Biopharma 0

Artax Biopharma no tiene ninguna noticia disponible.

Cookies policy We use proprietary and third-party cookies to improve our services and user experience. If you continue to browse, we believe you accept its use.

Accept